Lifecore Biomedical Inc (LFCR)
6.56
+0.17
(+2.66%)
USD |
NASDAQ |
Nov 08, 13:48
Lifecore Biomedical Revenue (TTM): 128.44M for Aug. 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| August 31, 2024 | 128.44M |
| May 31, 2024 | 128.26M |
| February 29, 2024 | 121.52M |
| November 30, 2023 | 112.35M |
| August 31, 2023 | 104.07M |
| May 31, 2023 | 103.27M |
| February 28, 2023 | 93.25M |
| November 30, 2022 | 104.12M |
| August 31, 2022 | 125.70M |
| May 31, 2022 | 143.61M |
| February 28, 2022 | 96.73M |
| November 30, 2021 | 104.02M |
| August 31, 2021 | 191.47M |
| May 31, 2021 | 285.48M |
| February 28, 2021 | 37.07M |
| November 30, 2020 | 145.31M |
| August 31, 2020 | 157.00M |
| May 31, 2020 | 160.07M |
| February 29, 2020 | 587.02M |
| November 30, 2019 | 589.64M |
| August 31, 2019 | 571.60M |
| May 31, 2019 | 557.56M |
| February 28, 2019 | 545.86M |
| November 30, 2018 | 535.21M |
| August 31, 2018 | 533.11M |
| Date | Value |
|---|---|
| May 31, 2018 | 524.23M |
| February 28, 2018 | 448.10M |
| November 30, 2017 | 439.76M |
| August 31, 2017 | 453.16M |
| May 31, 2017 | 469.78M |
| February 28, 2017 | 475.96M |
| November 30, 2016 | 469.38M |
| August 31, 2016 | 473.96M |
| May 31, 2016 | 476.92M |
| February 29, 2016 | 540.23M |
| November 30, 2015 | 548.77M |
| August 31, 2015 | 541.00M |
| May 31, 2015 | 539.26M |
| February 28, 2015 | 525.74M |
| November 30, 2014 | 513.59M |
| August 31, 2014 | 500.95M |
| May 31, 2014 | 476.81M |
| February 28, 2014 | 463.00M |
| November 30, 2013 | 454.48M |
| August 31, 2013 | 449.11M |
| May 31, 2013 | 441.71M |
| February 28, 2013 | 417.21M |
| November 30, 2012 | 379.41M |
| August 31, 2012 | 346.32M |
| May 31, 2012 | 317.55M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
37.07M
Minimum
Feb 2021
589.64M
Maximum
Nov 2019
175.92M
Average
126.98M
Median
Revenue (TTM) Benchmarks
| AngioDynamics Inc | 292.73M |
| Precision Optics Corp Inc | 19.10M |
| Sage Therapeutics Inc | 106.40M |
| Outset Medical Inc | 114.73M |
| NovaBay Pharmaceuticals Inc | 12.02M |